On

Oncoimmunology

OncoImmunology is a dynamic, high-profile, open access journal covering tumor immunology and immunotherapy, including basic and translational studies in solid and hematological malignancies, immune responses against cancer, cancer immunoediting and immune evasion, modern immunotherapies, and immunological effects of conventional anticancer therapies.

Looking to publish in Oncoimmunology? Livewrite integrates seamlessly with Word to help you write, edit, and format faster.

Try Livewrite Now
Subject Immunology, Oncology
Impact Factor 6.3
Quartile Q1
Open Access Type Open
ISSN 2162-402X
eISSN 2162-402X
Invitation Only Yes
Cost Range Article Publishing Charge (APC) required for open access publication; institutional agreements, discounts, and waivers may reduce or cover the APC

Submission Instructions

Oncoimmunology is an invitation-only journal. Submissions are accepted by invitation from the editorial board only. The following article types are accepted:

Research Article

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract is required. Abstract must be 250 words. Abstract must be unstructured.
Manuscript Manuscript must be no more than 5,000 words. Manuscript must be ordered as title page, abstract, keywords, introduction, materials and methods, results, discussion, acknowledgments, declaration of interest statement, references, appendices as appropriate, tables with captions on individual pages, figures, and figure captions as a list. Manuscript must include keywords and a declaration of interest statement.
References References must not exceed 80. References may be in any consistent scholarly citation style or format. References must include complete bibliographic details and every entry must have a corresponding in-text citation.
Figures & Tables Figures and tables are limited to a combined maximum of 8, with additional figures or tables permitted as supplementary material. Figures and tables may be placed within the text or submitted as separate documents.
Reformat to Oncoimmunology using Livewrite Premium

Review Articles

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract is required. Abstract must be 250 words. Abstract must be unstructured.
Manuscript Manuscript must be no more than 5,000 words. Manuscript must be ordered as title page, abstract, keywords, introduction, materials and methods, results, discussion, acknowledgments, declaration of interest statement, references, appendices as appropriate, tables with captions on individual pages, figures, and figure captions as a list. Manuscript must include keywords and a declaration of interest statement.
References References may be in any style or format if a consistent scholarly citation format is used. References must include the author name or names, journal or book title, article or chapter title, year of publication, volume and issue where appropriate, and page numbers, and every bibliographic entry must have a corresponding in-text citation.
Figures & Tables A maximum of 6 figures and tables combined is permitted, with additional figures or tables allowed in supplementary material. Tables with captions must appear on individual pages, followed by figures and then figure captions as a list.
Reformat to Oncoimmunology using Livewrite Premium

Brief Reports

Cover Letter Cover Letter requirements are not specified.
Abstract Abstract is required. Abstract must be 200 words. Abstract must be unstructured.
Manuscript Manuscript must be ordered as title page, abstract, keywords, prior presentations of the work, main text with Introduction, Materials and Methods, Results, and Discussion, acknowledgments, declaration of interest statement, references, appendices as appropriate, tables with captions on individual pages, figures, and figure captions as a list. Manuscript must include 5 to 10 keywords and a declaration of interest statement.
References References must not exceed 30. References may be in any consistent scholarly citation style or format. References must include author name or names, journal or book title, article or chapter title, year of publication, volume and issue where appropriate, and page numbers, and every bibliographic entry must have a corresponding in-text citation.
Figures & Tables There must be no more than 3 display items in total, with additional figures or tables allowed as supplementary material. Figures and tables may be placed within the text or submitted as separate documents.
Reformat to Oncoimmunology using Livewrite Premium

Recent Publications

Integrating tumor and immune cell transcriptomics to predict immune checkpoint inhibitor primary resistance in metastatic melanoma

Juan Luis Onieva, Elisabeth Pérez-Ruiz, Ville Vilkki, Miguel Berciano-Guerrero, Laura Figueroa-Ortiz, Manuel Zalabardo, Beatriz Martínez-Gálvez, Isabel Barragán, Antonio Rueda-Domínguez

10.1080/2162402x.2026.2650234
View Publication

2025 List of Reviewers for OncoImmunology

-

10.1080/2162402x.2026.2651599
View Publication

Sialic acid cis -ligand dynamics modulate Siglec-7 and -9 function and affect Siglec-7/9 co-blockade to potentiate natural killer cell anti-tumor activity

Jesper van Eck van der Sluijs, Anne H. C. Valk, Eline J. H. van Houtum, Esther D. Kers-Rebel, Maaike Looman, Willemijn Hobo, Anna E. Marneth, Harry Dolstra, Lune van den Boogaard, Christian Büll, Lenneke A. M. Cornelissen, Gosse J. Adema

10.1080/2162402x.2026.2649988
View Publication

Pharmacological inhibition of MAPK P38α rescues the immune defect of dendritic cells affected by the FPR1 loss-of-function polymorphism rs867228

Liwei Zhao, Oliver Kepp, Peng Liu, Guido Kroemer

10.1080/2162402x.2026.2652088
View Publication

Early local immune activation following intra-operative radiotherapy in human breast tissue

Anna Tiefenthaller, Nikko Brix, Roman Hennel, Montserrat Pazos, Bernd Kost, Vera von Bodungen, Brigitte Rack, Rachel Wuerstlein, Benjamin Frey, Udo S. Gaipl, Julia Hess, Kristian Unger, Benedek Dankó, Martin Selmansberger, Horst Zitzelsberger, Nadia Harbeck, Claus Belka, Heike Scheithauer, Kirsten Lauber

10.1080/2162402x.2026.2653318
View Publication

Frequently asked questions

How long does it take to publish?

3 days avg. from submission to first decision; 47 days avg. from submission to first post-review decision; 15 days avg. from acceptance to online publication.

Reformat to Oncoimmunology using Livewrite Premium

Is a cover letter required?

A cover letter is supported and guidance is provided, but it is not stated as required.

Reformat to Oncoimmunology using Livewrite Premium

What are the publication costs?

Article Publishing Charge (APC) may be required for publication. Institutional agreements, discounts, and waivers may reduce or cover the APC.

Reformat to Oncoimmunology using Livewrite Premium

Research Topics

Cancer Immunotherapy and Biomarkers Immunotherapy and Immune Responses Immune Cell Function and Interaction CAR-T cell therapy research Immune cells in cancer T-cell and B-cell Immunology Virus-based gene therapy research Monoclonal and Polyclonal Antibodies Research Immune Response and Inflammation Phagocytosis and Immune Regulation Cancer Cells and Metastasis Cancer Research and Treatments RNA Interference and Gene Delivery vaccines and immunoinformatics approaches Chemokine receptors and signaling interferon and immune responses Lymphoma Diagnosis and Treatment Ferroptosis and cancer prognosis Cancer, Stress, Anesthesia, and Immune Response Cytokine Signaling Pathways and Interactions Pancreatic and Hepatic Oncology Research Glioma Diagnosis and Treatment Cancer, Hypoxia, and Metabolism Adenosine and Purinergic Signaling Peptidase Inhibition and Analysis

Related Journals

GM
Gut Microbes Landes Bioscience
EI
Emerging Infectious Diseases CENTERS DISEASE CONTROL & PREVENTION
SI
Seminars In Cancer Biology Elsevier BV
JO
Journal Of Thoracic Oncology Elsevier BV
I&
Immunity & Ageing BioMed Central
BB
Brain Behavior And Immunity Elsevier BV